A synergetic effect of BARD1 mutations on tumorigenesis

To date, a large number of mutations have been screened from breast and ovarian cancer patients. However, most of them are classified into benign or unidentified alterations due to their undetectable phenotypes. Whether and how they could cause tumors remains unknown, and this significantly limits diagnosis and therapy. Here, in a study of a family with hereditary breast and ovarian cancer, we find that two BARD1 mutations, P24S and R378S, simultaneously exist in cis in surviving cancer patients. Neither of the single mutations causes a functional change, but together they synergetically impair the DNA damage response and lead to tumors in vitro and in vivo. Thus, our report not only demonstrates that BARD1 defects account for tumorigenesis but also uncovers the potential risk of synergetic effects between the large number of cis mutations in individual genes in the human genome.

For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability The WGS data reported in this study have been deposited in the genome sequence archive of Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China (gsa.big.ac.cn, accession no. CRA002326). The solution NMR structure of the BRCA1/BARD1 RING-domain heterodimer is available from http:// www1.rcsb.org/structure/1JM7. The remaining data are available within the Article, Supplementary information or available from the authors upon request.

Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.

Life sciences Behavioural & social sciences Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Sample size
No statistical methods were used to predetermine sample sizes. The sample sizes were chosen according to previous experience and on what is common practice in the field. For WGS, the number of sequenced samples of involved participants was determined by the proband and the related members in the family of Hereditary Breast and Ovarian Cancer.
Data exclusions No data were excluded from the analyses.

Replication
The experiments were performed in triplicate unless otherwise stated. Replication information is included in the Figure Legends and/or text. All replicates are sufficient for us to perform statistical tests when needed. All replicates were reproducible.
Randomization Samples were random allocated into experimental groups.

Blinding
The investigators were blinded to group allocation during data collection and analysis.

Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.

Authentication
Because no commonly misidentified cell lines were used in the study, morphology check by microscope was done for each cell line for authentication.

Mycoplasma contamination
All cell lines were tested negative for mycoplasma contamination.
Commonly misidentified lines (See ICLAC register) No commonly misidentified cell lines were used in the study.

Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research

Laboratory animals
Female BALB/c nude mice aged 4-6 weeks were used.

Wild animals
The study did not involve wild animals.
Field-collected samples The study did not involve samples collected from the field.

Ethics oversight
The Ethics Committee of Peking University Health Science Center approved the study protocol.
Note that full information on the approval of the study protocol must also be provided in the manuscript.

Human research participants
Policy information about studies involving human research participants

Recruitment
The family were recruited in this study on account of a typical characteristics of HBOC family in which multiple cases of breast cancer and/or ovarian cancer occurred on the same side of the family. We sampled the peripheral blood of all surviving female members including  for whole genomic sequencing, so there is no self-selection bias that could impact results.

Ethics oversight
All human materials used in this study was approved by Peking University Third Hospital Medical Science Research Ethic Committee (IRB00006761-M2019343). Signed informed consents were obtained from the family members who participated in the study.
Note that full information on the approval of the study protocol must also be provided in the manuscript.

Flow Cytometry
Plots Confirm that: The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.

Methodology Sample preparation
Cells expressing WT or mutant BARD1 variants were treated with or without 2 Gy of IR. After 1 hour of recovery, cells were fixed with 70% (v/v) ethanol, stained with rabbit antibody to phospho-histone H3 (pSer10), and then incubated with fluorescence-conjugated goat secondary antibody against rabbit. The stained cells were treated with RNase A and then dyed with propidium iodide.

Instrument
Flow Cytometer (BD FACSCelesta, BD Biosciences-US) was used for data collection.

Software
FlowJo V10 software was used to collect and analyze the flow cytometry data.

Cell population abundance
No post-sort fraction was used in the study.
Gating strategy FSC/SSC gates were used to remove debris and doublets while preserving single living cells based on size and complexity. The boundaries between "positive" and "negative" cell populations were clear and the "positive" populations were circled.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.